Fundies. English
Segment disclosures
Company overviewCIMG Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
8 dimension combinations 14 retained observations 5 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Computing Power Product Series · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=CIMG:ComputingPowerProductSeriesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-10-01 – 2026-06-30 | 7057088 | USD | 20260813 | Open filing evidence |
Homology Of Medicine And Food Series · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=CIMG:HomologyOfMedicineAndFoodSeriesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-10-01 – 2026-06-30 | 1871082 | USD | 20260813 | Open filing evidence |
Maca Product · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=CIMG:MacaProductMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-10-01 – 2026-06-30 | 12226947 | USD | 20260813 | Open filing evidence |
Adjustments And Eliminations · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=IMG:AdjustmentsAndEliminationsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-10-01 – 2025-09-30 | -891 | USD | 20260213 | Open filing evidence |
Computing Power Product Series · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=IMG:ComputingPowerProductSeriesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-10-01 – 2026-03-31 | 5010158 | USD | 20260511 | Open filing evidence |
| 2025-10-01 – 2025-12-31 | 2360373 | USD | 20260319 | Open filing evidence |
| 2024-10-01 – 2025-09-30 | 3804691 | USD | 20260213 | Open filing evidence |
Homology Of Medicine And Food Series · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=IMG:HomologyOfMedicineAndFoodSeriesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-10-01 – 2026-03-31 | 1855618 | USD | 20260511 | Open filing evidence |
| 2025-10-01 – 2025-12-31 | 1426832 | USD | 20260319 | Open filing evidence |
| 2024-10-01 – 2025-09-30 | 6349252 | USD | 20260213 | Open filing evidence |
Maca Product · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=IMG:MacaProductMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-10-01 – 2026-03-31 | 12118011 | USD | 20260511 | Open filing evidence |
| 2025-10-01 – 2025-12-31 | 11981591 | USD | 20260319 | Open filing evidence |
| 2024-10-01 – 2025-09-30 | 144726 | USD | 20260213 | Open filing evidence |
Maca Product Series
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=IMG:MacaProductSeriesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-10-01 – 2024-09-30 | 1930291 | USD | 20260213 | Open filing evidence |